-
Product Insights
Organophosphate and Carbamate Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Organophosphates and carbamates are common insecticides that inhibit cholinesterase activity, causing acute muscarinic manifestations (salivation, lacrimation, urination, diarrhea, emesis, bronchorrhea, bronchospasm, bradycardia, miosis) and some nicotinic symptoms, including muscle fasciculations and weakness. Most patients have bradycardia and, if poisoning is severe, hypotension. CNS toxicity is common, sometimes with seizures and excitability and often with lethargy and coma. Pancreatitis is possible, and organophosphates may cause arrhythmias such as heart block and QTc interval prolongation. The Organophosphate and Carbamate Poisoning pipeline drugs...
-
Product Insights
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2022, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline landscape. Radiation Toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of penetrating radiation in a very short period of time (usually a matter of minutes). The major cause of this syndrome...
-
Product Insights
Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Drug Overdose can occur with multiple symptoms including sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Treatment includes antidote and activated charcoal. The Drug Overdose pipeline market report provides a comprehensive overview of the therapeutics under development for Drug Overdose, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Heavy Metal Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Heavy Metal Poisoning pipeline market report provides a comprehensive overview of the therapeutics under development for Heavy Metal Poisoning, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Heavy Metal...
-
Product Insights
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Chemotherapy-induced Anemia pipeline market research report provides a comprehensive overview on the therapeutics under development for Chemotherapy-induced Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chemotherapy-induced Anemia and features...
-
Product Insights
Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Chemotherapy-induced Peripheral Neuropathy - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Chemotherapy-induced Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for...
-
Product Insights
Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Opioid Overdosage pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Chemotherapy Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chemotherapy Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chemotherapy Effects pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Effects, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Drug Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Drug Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Drug Toxicity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Drug Toxicity, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chemotherapy-Induced Diarrhea (CID) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy-Induced Diarrhea (CID), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Radiation Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Radiation Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pulmonary Radiation Toxicity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Radiation Toxicity , complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Chemotherapy Induced Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chemotherapy Induced Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chemotherapy Induced Oral Mucositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Oral Mucositis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Gastrointestinal Radiation Toxicity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Radiation Toxicity, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Chemotherapy Induced Nausea and Vomiting Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2020" provides an overview of Chemotherapy Induced Nausea and Vomiting Clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Nausea and Vomiting. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.